Neurogastrx Bags $45M, a New CEO and a HQ Move to the Greater Boston Area Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Series A financing was co-led by 5AM Ventures, OrbiMed Advisors and venBio Partners. Source: BioSpace You Might Also Like Doctors Accuse NextSource Biotech for Hiking the Price on Key Cancer Drug Nine Times December 27, 2017 Ignyta Reports Granting Of Inducement Awards September 17, 2017 FDA Berates Lupin for Repeatedly Making Pills That Don't Meet Quality Standards November 15, 2017
Doctors Accuse NextSource Biotech for Hiking the Price on Key Cancer Drug Nine Times December 27, 2017
